Ocuphire Pharma
Latest round
- Seed
Last raised
- Jul 2019
Total raised
- $5M
Investors
- 9
About Ocuphire Pharma
Ocuphire Pharma, Inc.Founded in 2018 and headquartered in Farmington Hills, US, Ocuphire Pharma specializes in developing therapies for ophthalmic conditions. The company has not undergone significant business pivots.13 mn.Ocuphire Pharma specializes in developing treatments for various ophthalmic conditions. Their product offerings are centered on innovative solutions targeting eye disorders, including therapies that aim to improve vision and overall eye health.Ocuphire Pharma generates revenue through partnerships and collaborations with healthcare institutions and research organizations.Ocuphire Pharma plans to advance its product pipeline by launching new therapies designed for specific ophthalmic conditions in the coming years. The company aims to expand its market presence beyond North America and Europe into other global regions by 2024.13 mn will be utilized to support these growth initiatives, including further development of their therapeutic offerings.
Who invested in Ocuphire Pharma
9 investors across 1 round
See all investors in Ocuphire Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 22, 2019
Amount
$5M
Investors
Questions about Ocuphire Pharma
Who invested in Ocuphire Pharma?
Ocuphire Pharma has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ocuphire Pharma raised?
Ocuphire Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ocuphire Pharma last raise money?
Ocuphire Pharma's most recent round on record is a Seed, in Jul 2019.
What does Ocuphire Pharma do?
Ocuphire Pharma is a biotechnology company.
Where is Ocuphire Pharma headquartered?
Ocuphire Pharma is headquartered in Farmington Hills, US.
Which VCs invest in companies like Ocuphire Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ocuphire Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ocuphire Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.